Literature DB >> 23181429

Diversity of allosteric regulation in proteases.

Melisa Merdanovic1, Timon Mönig, Michael Ehrmann, Markus Kaiser.   

Abstract

Allostery is a fundamental regulatory mechanism that is based on a functional modulation of a site by a distant site. Allosteric regulation can be triggered by binding of diverse allosteric effectors, ranging from small molecules to macromolecules, and is therefore offering promising opportunities for functional modulation in a wide range of applications including the development of chemical probes or drug discovery. Here, we provide an overview of key classes of allosteric protease effectors, their corresponding molecular mechanisms, and their practical implications.

Mesh:

Substances:

Year:  2012        PMID: 23181429     DOI: 10.1021/cb3005935

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  22 in total

1.  Allosteric inhibition of factor XIa. Sulfated non-saccharide glycosaminoglycan mimetics as promising anticoagulants.

Authors:  Rami A Al-Horani; David Gailani; Umesh R Desai
Journal:  Thromb Res       Date:  2015-04-22       Impact factor: 3.944

2.  Rational Design of Selective Allosteric Inhibitors of PHGDH and Serine Synthesis with Anti-tumor Activity.

Authors:  Qian Wang; Maria V Liberti; Pei Liu; Xiaobing Deng; Ying Liu; Jason W Locasale; Luhua Lai
Journal:  Cell Chem Biol       Date:  2016-12-29       Impact factor: 8.116

Review 3.  Detecting Allosteric Networks Using Molecular Dynamics Simulation.

Authors:  S Bowerman; J Wereszczynski
Journal:  Methods Enzymol       Date:  2016-06-20       Impact factor: 1.600

Review 4.  Factor XIIIa inhibitors as potential novel drugs for venous thromboembolism.

Authors:  Rami A Al-Horani; Srabani Kar
Journal:  Eur J Med Chem       Date:  2020-05-18       Impact factor: 6.514

5.  The SUMO1-E67 interacting loop peptide is an allosteric inhibitor of the dipeptidyl peptidases 8 and 9.

Authors:  Esther Pilla; Markus Kilisch; Christof Lenz; Henning Urlaub; Ruth Geiss-Friedlander
Journal:  J Biol Chem       Date:  2013-09-26       Impact factor: 5.157

6.  Dual functionality of β-tryptase protomers as both proteases and cofactors in the active tetramer.

Authors:  Henry R Maun; Peter S Liu; Yvonne Franke; Charles Eigenbrot; William F Forrest; Lawrence B Schwartz; Robert A Lazarus
Journal:  J Biol Chem       Date:  2018-04-16       Impact factor: 5.157

Review 7.  Sulfated Non-Saccharide Glycosaminoglycan Mimetics as Novel Drug Discovery Platform for Various Pathologies.

Authors:  Daniel K Afosah; Rami A Al-Horani
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

8.  Allosterism-based simultaneous, dual anticoagulant and antiplatelet action: allosteric inhibitor targeting the glycoprotein Ibα-binding and heparin-binding site of thrombin.

Authors:  A Y Mehta; B M Mohammed; E J Martin; D F Brophy; D Gailani; U R Desai
Journal:  J Thromb Haemost       Date:  2016-02-16       Impact factor: 5.824

9.  A small group of sulfated benzofurans induces steady-state submaximal inhibition of thrombin.

Authors:  Daniel K Afosah; Stephen Verespy; Rami A Al-Horani; Rio S Boothello; Rajesh Karuturi; Umesh R Desai
Journal:  Bioorg Med Chem Lett       Date:  2018-02-03       Impact factor: 2.823

10.  Allosteric inhibition of the NS2B-NS3 protease from dengue virus.

Authors:  Muslum Yildiz; Sumana Ghosh; Jeffrey A Bell; Woody Sherman; Jeanne A Hardy
Journal:  ACS Chem Biol       Date:  2013-10-28       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.